Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | -33,940 | -49,070 | -96,490 |
| Depreciation Amortization | N/A | N/A | 8,270 | 6,670 | 4,870 |
| Other Working Capital | N/A | N/A | 620 | -1,510 | -2,320 |
| Other Operating Activity | 0 | 0 | -10,200 | 5,470 | 59,330 |
| Operating Cash Flow | $N/A | $N/A | $-35,250 | $-38,440 | $-34,610 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -2,480 | -2,030 | -1,320 |
| Net Acquisitions | N/A | N/A | -1,970 | -6,970 | 0 |
| Other Investing Activity | 0 | 0 | 7,400 | 8,840 | 6,720 |
| Investing Cash Flow | $N/A | $N/A | $2,950 | $-160 | $5,400 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 26,320 | 44,510 | 20,080 |
| Financing Cash Flow | $N/A | $N/A | $26,320 | $44,510 | $20,080 |
| Exchange Rate Effect | N/A | N/A | 510 | -840 | -50 |
| Beginning Cash Position | N/A | N/A | 11,260 | 6,190 | 15,370 |
| End Cash Position | N/A | N/A | 5,800 | 11,260 | 6,190 |
| Net Cash Flow | $N/A | $N/A | $-5,450 | $5,060 | $-9,170 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | -35,250 | -38,440 | -34,610 |
| Free Cash Flow | 0 | 0 | -35,250 | -38,440 | -34,610 |